Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
Go back to Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 12.33 +0.36 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.97 | 52 Week High | $2.18 | |||
| Open | $12.13 | 52 Week Low | $0.30 | |||
| Day High | $12.33 | P/E | N/A | |||
| Day Low | $12.12 | EPS | $-3.32 | |||
| Volume | 85,116 | |||||
